Pajjiż: Ingilterra
Lingwa: Ingliż
Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)
Flupentixol decanoate
Lundbeck Ltd
N05AF01
Flupentixol decanoate
100mg/1ml
Solution for injection
Intramuscular
No Controlled Drug Status
Valid as a prescribable product
BNF: 04020200; GTIN: 5702157120307
Package leaflet: Information for the patient DEPIXOL ® CONC. 100 MG/ML SOLUTION FOR INJECTION FLUPENTIXOL DECANOATE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again • If you have any further questions, ask your doctor, pharmacist or nurse • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. WHAT DEPIXOL CONC. INJECTION IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE DEPIXOL CONC. INJECTION IS GIVEN 3. HOW DEPIXOL CONC. INJECTION IS GIVEN 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE DEPIXOL CONC. INJECTION 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT DEPIXOL CONC. INJECTION IS AND WHAT IT IS USED FOR The name of your medicine is Depixol Conc. 100 mg/ml solution for injection (called Depixol Conc. Injection in this leaflet). Depixol Conc. Injection contains the active substance flupentixol decanoate. Depixol Conc. Injection belongs to a group of medicines known as antipsychotics (also called neuroleptics). These medicines act on nerve pathways in specific areas of the brain and help to correct certain chemical imbalances in the brain that are causing the symptoms of your illness. Depixol Conc. Injection is used for the treatment of schizophrenia and other psychoses. Your doctor, however, may prescribe Depixol Conc. Injection for another purpose. Ask your doctor if you have any questions about why Depixol Conc. Injection has been prescribed for you. 2. WHAT YOU NEED TO KNOW BEFORE DEPIXOL CONC. INJECTION IS GIVEN DEPIXOL CONC. INJECTION IS NOT GIVEN IF YOU • are allergic (hypersensitive) to flupentixol, other thioxanthene drugs or antipsychotic drugs or any of the other ingredients of this m Aqra d-dokument sħiħ
OBJECT 1 DEPIXOL 20 MG/ML SOLUTION FOR INJECTION Summary of Product Characteristics Updated 06-Apr-2017 | Lundbeck Limited 1. Name of the medicinal product Depixol ® 20 mg/ml solution for injection Depixol ® Conc. 100 mg/ml solution for injection 2. Qualitative and quantitative composition Depixol Injection: 20 mg/ml flupentixol decanoate in thin vegetable oil. Depixol Conc. Injection: 100 mg/ml flupentixol decanoate in thin vegetable oil. For the full list of excipients, see section 6.1 3. Pharmaceutical form Solution for injection. Depixol Injection: Clear, colourless to slightly yellowish oil, practically free from particles. Depixol Conc. Injection: Clear, yellowish to yellow oil, practically free from particles. Oily solution for deep intramuscular injection. 4. Clinical particulars 4.1 Therapeutic indications The treatment of schizophrenia and other psychoses. Use of Depixol should be restricted to those stabilised on oral therapy. 4.2 Posology and method of administration Posology _Adults_ The usual dosage of flupentixol decanoate lies between 50 mg every 4 weeks and 300 mg every 2 weeks, but some patients may require up to 400 mg weekly. The maximum single dose at any one time is 400 mg. For example, 800 mg ever 2 weeks should not be given. Other patients may be adequately maintained on dosages of 20-40 mg flupentixol decanoate every 2-4 weeks. In patients who have not previously received depot antipsychotic, treatment is usually started with a small dose (e.g. 20 mg) to assess tolerability. An interval of at least one week should be allowed before the second injection is given at a dose consistent with the patients' condition. Depixol Injection 20 mg/ml is not intended for use in patients requiring doses of greater than 60 mg (3 ml) of flupentixol. Injection volumes of 2 – 3 ml should be distributed between two injection sites. More concentrated solutions of flupentixol decanoate (Depixol Conc Injection or Depixol Low Volume Injection) should be used if doses greater than 3 ml (60 mg) are required. T Aqra d-dokument sħiħ